Analytical Data
-
Gene name
H1-1
- Application
-
Alternative Names
H1 VAR.3Histone H1a ;H1a
-
Species
Mouse
-
Source
E. coli
-
Tag
N- GST
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P43275
-
Expression Region
2-213aa
-
Molecular Weight
48.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
H1-1 recombinant protein, derived from the human immune response, plays a significant role in immunological research due to its potential therapeutic applications. This protein is a member of the H1 family, which is known for its involvement in modulating immune responses. The increasing prevalence of autoimmune diseases and the need for targeted therapies have spurred interest in understanding how H1-1 can influence immune cell signaling and function. Research has shown that H1-1 can interact with various immune receptors and cytokines, suggesting its potential to enhance or regulate immune responses. Furthermore, studies indicate that H1-1 may have a role in tumor immunology, making it a candidate for cancer immunotherapy. The recombinant expression of H1-1 facilitates detailed investigations into its biological activities, allowing scientists to explore its mechanisms of action and therapeutic potential. Overall, the study of H1-1 recombinant protein is at the forefront of developing new strategies for treating immune-related disorders, contributing to advancements in biomedicine and therapeutic interventions.
